中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 3
Mar.  2023
Turn off MathJax
Article Contents

A case of Danon's disease with recurrent abnormal liver function

DOI: 10.3969/j.issn.1001-5256.2023.03.022
Research funding:

General Project of Basic Research of Guizhou Department of Science and Technology (Guizhou Science and Technology Cooperation Foundation-ZK〔2022〕General 646)

More Information
  • Corresponding author: ZHU Rong, rongzhuzhurong@126.com (ORCID: 0000-0002-4795-0180)
  • Received Date: 2022-07-22
  • Accepted Date: 2022-10-26
  • Published Date: 2023-03-20
  • loading
  • [1]
    DANON MJ, OH SJ, DIMAURO S, et al. Lysosomal glycogen storage disease with normal acid maltase[J]. Neurology, 1981, 31(1): 51-57. DOI: 10.1212/wnl.31.1.51.
    [2]
    NISHINO I, FU J, TANJI K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)[J]. Nature, 2000, 406(6798): 906-910. DOI: 10.1038/35022604.
    [3]
    CHI C, RICHING AS, SONG K. Lysosomal abnormalities in cardiovascular disease[J]. Int J Mol Sci, 2020, 21(3): 811. DOI: 10.3390/ijms21030811.
    [4]
    CHI C, LEONARD A, KNIGHT WE, et al. LAMP-2B regulates human cardiomyocyte function by mediating autophagosome-lysosome fusion[J]. Proc Natl Acad Sci U S A, 2019, 116(2): 556-565. DOI: 10.1073/pnas.1808618116.
    [5]
    CENACCHI G, PAPA V, PEGORARO V, et al. Review: Danon disease: Review of natural history and recent advances[J]. Neuropathol Appl Neurobiol, 2020, 46(4): 303-322. DOI: 10.1111/nan.12587.
    [6]
    CHARRON P, VILLARD E, SÉBILLON P, et al. Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey[J]. Heart, 2004, 90(8): 842-846. DOI: 10.1136/hrt.2003.029504.
    [7]
    FU L, LUO S, CAI S, et al. Identification of LAMP2 mutations in early-onset danon disease with hypertrophic cardiomyopathy by targeted next-generation sequencing[J]. Am J Cardiol, 2016, 118(6): 888-894. DOI: 10.1016/j.amjcard.2016.06.037.
    [8]
    GUO S, ZHOU L, WANG R, et al. Danon disease: Two patients with atrial fibrillation in a single family and review of the literature[J]. Exp Ther Med, 2019, 18(3): 1527-1532. DOI: 10.3892/etm.2019.7777.
    [9]
    CHEN X, FU L, HE J, et al. A frequent observation of wolff-parkinson-white syndrome and fasciculoventricular pathways in patients with danon disease[J]. Circ J, 2022, 86(2): 309-318. DOI: 10.1253/circj.CJ-21-0572.
    [10]
    SUGIE K, YAMAMOTO A, MURAYAMA K, et al. Clinicopathological features of genetically confirmed Danon disease[J]. Neurology, 2002, 58(12): 1773-1778. DOI: 10.1212/wnl.58.12.1773.
    [11]
    ZHANG Y, REN H, ZHOU S. A case report of delayed diagnosis of danon disease: Caused by a newly recognized mutation in the lysosome-associated membrane protein-2 gene[J]. Medicine (Baltimore), 2020, 99(40): e22640. DOI: 10.1097/MD.0000000000022640.
    [12]
    BOUCEK D, JIRIKOWIC J, TAYLOR M. Natural history of Danon disease[J]. Genet Med, 2011, 13(6): 563-568. DOI: 10.1097/GIM.0b013e31820ad795.
    [13]
    D'SOUZA RS, LEVANDOWSKI C, SLAVOV D, et al. Danon disease: clinical features, evaluation, and management[J]. Circ Heart Fail, 2014, 7(5): 843-849. DOI: 10.1161/CIRCHEARTFAILURE.114.001105.
    [14]
    GURKA J, PIHEROVA L, MAJER F, et al. Danon disease is an underdiagnosed cause of advanced heart failure in young female patients: a LAMP2 flow cytometric study[J]. ESC Heart Fail, 2020, 7(5): 2534-2543. DOI: 10.1002/ehf2.12823.
    [15]
    MANSO AM, HASHEM SI, NELSON BC, et al. Systemic AAV9. LAMP2B injection reverses metabolic and physiologic multiorgan dysfunction in a murine model of Danon disease[J]. Sci Transl Med, 2020, 12(535). DOI: 10.1126/scitranslmed.aax1744.
    [16]
    XUE R, FAN JG. Brief introduction of an international expert consensus statement: A new definition of metabolic associated fatty liver disease[J]. J Clin Hepatol, 2020, 36(6): 1224-1227. DOI: 10.3969/j.issn.1001-5256.2020.06.007.

    薛芮, 范建高. 代谢相关脂肪性肝病新定义的国际专家共识简介[J]. 临床肝胆病杂志, 2020, 36(6): 1224-1227. DOI: 10.3969/j.issn.1001-5256.2020.06.007.
    [17]
    LEE SB, PARK GM, LEE JY, et al. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study[J]. J Hepatol, 2018, 68(5): 1018-1024. DOI: 10.1016/j.jhep.2017.12.012.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)

    Article Metrics

    Article views (404) PDF downloads(113) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return